Feature | August 06, 2014

Medtronic, Acist Enter Agreement to Commercialize Next Generation FFR-IVUS Technologies

Collaboration provides increased commercial reach, brand synergies and customer access to new technologies

Medtronic, Acist Agreement FFR-IVUS Technologies

August 6, 2014  — Acist Medical Systems announced it entered into a strategic agreement with Medtronic to co-promote the world’s first Rapid Exchange FFR (RXi) and high definition IVUS (HDi) technologies in the United States. Under this agreement, Acist and Medtronic will work collaboratively to introduce these groundbreaking products into cardiac catheterization laboratories across the United States.

Fractional flow reserve (FFR) has quickly become the standard that interventional cardiologists use to determine which patients can most benefit from stenting. Intravascular ultrasound (IVUS) is an advanced diagnostic modality that provides greater insight into arterial disease than standard angiography alone. The Acist RXi and HDi systems are quicker, easier to use and offer detailed insight that physicians can use to optimize treatment choice for their patients.

Through this collaboration, Acist and Medtronic will bring this technology to existing and new customers who value improved modalities that simplify procedures and benefit their patients.

Acist’s new Rapid FFR system, which utilizes the ultra-thin Acist Navvus Rapid Exchange MicroCatheter and RXi console, was introduced earlier this year in the United States and Europe. The Navvus MicroCatheter can be used over a standard 0.014-inch guidewire, and the RXi system facilitates rapid FFR assessments before, during and post-intervention. This technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.

This agreement makes Acist/Medtronic the forth vendor for FFR and IVUS systems in the U.S. market.

For more information: www.acist.com, www.bracco.com, www.medtronic.com

Related Content

Absorb, bioresorbable stent, BVS
Feature | Stents Bioresorbable| July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth revolution of inte
3-D OCT

A 3-D OCT rendering of a stented vessel segment created on St. Jude Medical's Ilumien Optis OCT system. 

Feature | Angiography| July 15, 2016 | Dave Fornell
While angiographic X-ray fluoroscopy systems are the workhorse for transcatheter cardiovascular interventional proced
HeartFlow, FFR-CT Analysis, next-generation platform, second FDA clearance
Technology | CT Angiography (CTA)| June 29, 2016
HeartFlow Inc. announced that it is launching its next generation of the HeartFlow FFR-CT Analysis. The result of years...
St. Jude Medical, EuroPCR 2016 studies, FFR, LAAO, left atrial appendage occlusion, fractional flow reserve, Amplatzer
News | Cath Lab| May 19, 2016
St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR 2016.
vulnerable plaques, OCT, IVUS, catheter, combination, NIBIB study

The dual catheter OCT-IVUS imaging device can be inserted into an artery to simultaneously capture an infrared image of the arterial wall (OCT, at left) and an ultrasound image (IVUS, right) that doctors use to determine the potential that a plaque is susceptible to rupture that could cause a heart attack or stroke.

News | Intravascular Imaging| May 12, 2016
May 12, 2016 — Collaboration between two National Institute of Biomedical Imaging and Bioengineering (NIBIB)-funded l
Feature | Business| April 28, 2016 | Dave Fornell
 
FFR-CT, heartflow
Feature | CT Angiography (CTA)| April 15, 2016 | Jeff Zagoudis
Fractional flow reserve-computed tomography (FFR-CT) is still in the early stages of clinical implementation in the U
Sponsored Content | Videos | CT Angiography (CTA)| April 12, 2016
A discussion on the adoption rate of FFR-CT with Dr. Campbell Rogers, chief medical officer of HeartFlow.
Philips Volcano, iFR outcomes trials, vs FFR, DEFINE-FLAIR, iFR SWEDEHEART, SYNTAX II
News | FFR Catheters| April 05, 2016
April 5, 2016 — Philips announced that a combined total of more than 5,000 patients have been enrolled in three prosp
FFR-CT, HeartFlow, PLATFORM trial, one-year results, ACC 2016
News | CT Angiography (CTA)| April 05, 2016
Novel technology developed by HeartFlow Inc. significantly reduces the need for invasive procedures to diagnose...
Overlay Init